[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Nausea Medicine Market Report 2017

November 2017 | 99 pages | ID: UE5436505B7WEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Nausea Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Nausea Medicine in these regions, from 2012 to 2022 (forecast).
United States Nausea Medicine market competition by top manufacturers/players, with Nausea Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Merck & Co Inc (U.S.)
  • Sanofi (France)
  • TESARO (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Pfizer (U.S.)
  • GlaxoSmithKline (U.S.)
  • ANI Pharmaceuticals (U.S.)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Antacids
  • Antagonists
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nausea Medicine for each application, including
  • Hospitals
  • Clinics
  • Pharmaceutical Companies
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Nausea Medicine Market Report 2017

1 NAUSEA MEDICINE OVERVIEW

1.1 Product Overview and Scope of Nausea Medicine
1.2 Classification of Nausea Medicine by Product Category
  1.2.1 United States Nausea Medicine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Nausea Medicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Antacids
  1.2.4 Antagonists
1.3 United States Nausea Medicine Market by Application/End Users
  1.3.1 United States Nausea Medicine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Pharmaceutical Companies
1.4 United States Nausea Medicine Market by Region
  1.4.1 United States Nausea Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Nausea Medicine Status and Prospect (2012-2022)
  1.4.3 Southwest Nausea Medicine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Nausea Medicine Status and Prospect (2012-2022)
  1.4.5 New England Nausea Medicine Status and Prospect (2012-2022)
  1.4.6 The South Nausea Medicine Status and Prospect (2012-2022)
  1.4.7 The Midwest Nausea Medicine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nausea Medicine (2012-2022)
  1.5.1 United States Nausea Medicine Sales and Growth Rate (2012-2022)
  1.5.2 United States Nausea Medicine Revenue and Growth Rate (2012-2022)

2 UNITED STATES NAUSEA MEDICINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nausea Medicine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nausea Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nausea Medicine Average Price by Players/Suppliers (2012-2017)
2.4 United States Nausea Medicine Market Competitive Situation and Trends
  2.4.1 United States Nausea Medicine Market Concentration Rate
  2.4.2 United States Nausea Medicine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nausea Medicine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NAUSEA MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Nausea Medicine Sales and Market Share by Region (2012-2017)
3.2 United States Nausea Medicine Revenue and Market Share by Region (2012-2017)
3.3 United States Nausea Medicine Price by Region (2012-2017)

4 UNITED STATES NAUSEA MEDICINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Nausea Medicine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nausea Medicine Revenue and Market Share by Type (2012-2017)
4.3 United States Nausea Medicine Price by Type (2012-2017)
4.4 United States Nausea Medicine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NAUSEA MEDICINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Nausea Medicine Sales and Market Share by Application (2012-2017)
5.2 United States Nausea Medicine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NAUSEA MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co Inc (U.S.)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nausea Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co Inc (U.S.) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi (France)
  6.2.2 Nausea Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi (France) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 TESARO (U.S.)
  6.3.2 Nausea Medicine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 TESARO (U.S.) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F. Hoffmann-La Roche Ltd (Switzerland)
  6.4.2 Nausea Medicine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F. Hoffmann-La Roche Ltd (Switzerland) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer (U.S.)
  6.5.2 Nausea Medicine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer (U.S.) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline (U.S.)
  6.6.2 Nausea Medicine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline (U.S.) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 ANI Pharmaceuticals (U.S.)
  6.7.2 Nausea Medicine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 ANI Pharmaceuticals (U.S.) Nausea Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 NAUSEA MEDICINE MANUFACTURING COST ANALYSIS

7.1 Nausea Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nausea Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nausea Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nausea Medicine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NAUSEA MEDICINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Nausea Medicine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nausea Medicine Sales Volume Forecast by Type (2017-2022)
11.3 United States Nausea Medicine Sales Volume Forecast by Application (2017-2022)
11.4 United States Nausea Medicine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Nausea Medicine
Figure United States Nausea Medicine Market Size (K Units) by Type (2012-2022)
Figure United States Nausea Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Antacids Product Picture
Figure Antagonists Product Picture
Figure United States Nausea Medicine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Nausea Medicine by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Pharmaceutical Companies Examples
Table Key Downstream Customer in Pharmaceutical Companies
Figure United States Nausea Medicine Market Size (Million USD) by Region (2012-2022)
Figure The West Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nausea Medicine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Nausea Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nausea Medicine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Nausea Medicine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Nausea Medicine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nausea Medicine Sales Share by Players/Suppliers
Figure 2017 United States Nausea Medicine Sales Share by Players/Suppliers
Figure United States Nausea Medicine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nausea Medicine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nausea Medicine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nausea Medicine Revenue Share by Players/Suppliers
Figure 2017 United States Nausea Medicine Revenue Share by Players/Suppliers
Table United States Market Nausea Medicine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Nausea Medicine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Nausea Medicine Market Share of Top 3 Players/Suppliers
Figure United States Nausea Medicine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nausea Medicine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nausea Medicine Product Category
Table United States Nausea Medicine Sales (K Units) by Region (2012-2017)
Table United States Nausea Medicine Sales Share by Region (2012-2017)
Figure United States Nausea Medicine Sales Share by Region (2012-2017)
Figure United States Nausea Medicine Sales Market Share by Region in 2016
Table United States Nausea Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nausea Medicine Revenue Share by Region (2012-2017)
Figure United States Nausea Medicine Revenue Market Share by Region (2012-2017)
Figure United States Nausea Medicine Revenue Market Share by Region in 2016
Table United States Nausea Medicine Price (USD/Unit) by Region (2012-2017)
Table United States Nausea Medicine Sales (K Units) by Type (2012-2017)
Table United States Nausea Medicine Sales Share by Type (2012-2017)
Figure United States Nausea Medicine Sales Share by Type (2012-2017)
Figure United States Nausea Medicine Sales Market Share by Type in 2016
Table United States Nausea Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nausea Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nausea Medicine by Type (2012-2017)
Figure Revenue Market Share of Nausea Medicine by Type in 2016
Table United States Nausea Medicine Price (USD/Unit) by Types (2012-2017)
Figure United States Nausea Medicine Sales Growth Rate by Type (2012-2017)
Table United States Nausea Medicine Sales (K Units) by Application (2012-2017)
Table United States Nausea Medicine Sales Market Share by Application (2012-2017)
Figure United States Nausea Medicine Sales Market Share by Application (2012-2017)
Figure United States Nausea Medicine Sales Market Share by Application in 2016
Table United States Nausea Medicine Sales Growth Rate by Application (2012-2017)
Figure United States Nausea Medicine Sales Growth Rate by Application (2012-2017)
Table Merck & Co Inc (U.S.) Basic Information List
Table Merck & Co Inc (U.S.) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co Inc (U.S.) Nausea Medicine Sales Growth Rate (2012-2017)
Figure Merck & Co Inc (U.S.) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure Merck & Co Inc (U.S.) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table Sanofi (France) Basic Information List
Table Sanofi (France) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi (France) Nausea Medicine Sales Growth Rate (2012-2017)
Figure Sanofi (France) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure Sanofi (France) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table TESARO (U.S.) Basic Information List
Table TESARO (U.S.) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TESARO (U.S.) Nausea Medicine Sales Growth Rate (2012-2017)
Figure TESARO (U.S.) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure TESARO (U.S.) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Ltd (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd (Switzerland) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Nausea Medicine Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table Pfizer (U.S.) Basic Information List
Table Pfizer (U.S.) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer (U.S.) Nausea Medicine Sales Growth Rate (2012-2017)
Figure Pfizer (U.S.) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure Pfizer (U.S.) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline (U.S.) Basic Information List
Table GlaxoSmithKline (U.S.) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (U.S.) Nausea Medicine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline (U.S.) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline (U.S.) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table ANI Pharmaceuticals (U.S.) Basic Information List
Table ANI Pharmaceuticals (U.S.) Nausea Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ANI Pharmaceuticals (U.S.) Nausea Medicine Sales Growth Rate (2012-2017)
Figure ANI Pharmaceuticals (U.S.) Nausea Medicine Sales Market Share in United States (2012-2017)
Figure ANI Pharmaceuticals (U.S.) Nausea Medicine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nausea Medicine
Figure Manufacturing Process Analysis of Nausea Medicine
Figure Nausea Medicine Industrial Chain Analysis
Table Raw Materials Sources of Nausea Medicine Major Players/Suppliers in 2016
Table Major Buyers of Nausea Medicine
Table Distributors/Traders List
Figure United States Nausea Medicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Nausea Medicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nausea Medicine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Nausea Medicine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nausea Medicine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Nausea Medicine Sales Volume (K Units) Forecast by Type in 2022
Table United States Nausea Medicine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nausea Medicine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Nausea Medicine Sales Volume (K Units) Forecast by Application in 2022
Table United States Nausea Medicine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Nausea Medicine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nausea Medicine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nausea Medicine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories